Medicare Enrolled

Dr. Michael Damiano, M.D.

Optician · Wayne, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
995 OLD EAGLE SCHOOL RD, Wayne, PA 19087
6106883099
In practice since 2005 (20 years)
NPI: 1326039413 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Damiano from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Damiano? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Damiano

Dr. Michael Damiano is an optician specialist in Wayne, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Damiano performed 1,163 Medicare services across 689 unique beneficiaries.

Between the years covered by Open Payments, Dr. Damiano received a total of $1,921 from 26 pharmaceutical and/or device companies across 63 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Damiano is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 27% volume in PA $1,921 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,163
Medicare services
Top 27% in PA for optician
689
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~58 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
347 $5 $11
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
219 $33 $81
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
166 $46 $163
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
159 $31 $107
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
105 $20 $89
Destruction of cancer skin growth, 0.6-1.0 cm
This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters.
41 $85 $237
Intermediate wound repair, 2.6-7.5 cm
A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing.
33 $228 $487
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
27 $33 $142
Skin cancer removal, face or mouth area, 0.6-1.0 cm
Surgical removal of a cancerous skin growth from the face, ears, eyelids, nose, lips, or mouth. The procedure involves excising a lesion measuring between 0.6 and 1.0 centimeters.
19 $102 $382
Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm 18 $256 $509
Removal of noncancer skin growth, 0.6-1.0 cm
This procedure involves the removal of a benign skin growth located on the body, arms, or legs. The growth removed measures between 0.6 and 1.0 centimeters in diameter.
15 $68 $250
Surgical removal of skin cancer, 1.1-2.0 cm
Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs.
14 $106 $391
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,921
Total received (2018-2024)
Avg $274/year across 7 years
Top 36% in PA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
63
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,921 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$92
2023
$128
2022
$418
2021
$418
2020
$250
2019
$312
2018
$303

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$92
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$206
AbbVie Inc.
$182
Amgen Inc.
$140
Merck Sharp & Dohme Corporation
$125
Paratek Pharmaceuticals, Inc.
$123
Flexion Therapeutics, Inc.
$119
UCB, Inc.
$113
Boehringer Ingelheim Pharmaceuticals, Inc.
$102
Regeneron Healthcare Solutions, Inc.
$97
Bayer HealthCare Pharmaceuticals Inc.
$94
LEO Pharma Inc.
$86
ABBVIE INC.
$66
Janssen Biotech, Inc.
$65
Lilly USA, LLC
$64
Sientra, Inc.
$59
AbbVie, Inc.
$57
Galderma Laboratories, L.P.
$34
Novartis Pharmaceuticals Corporation
$31
Incyte Corporation
$29
NOVARTIS PHARMACEUTICALS CORPORATION
$23
PFIZER INC.
$22
Sun Pharmaceutical Industries Inc.
$20
MAYNE PHARMA INC.
$20
Sandoz Inc.
$16
Ortho Dermatologics, a division of Bausch Health US, LLC
$14
Sensus Healthcare, Inc.
$13
Top 3 companies account for 27.5% of all-time payments
Associated products mentioned in payments ›
ADBRY · ARAZLO · Aimovig · COSENTYX · Cimzia · DIFICID · DORYX · DUPIXENT · EPIDUO FORTE · EUCRISA · FASENRA · HUMIRA · Humira · ILUMYA · JARDIANCE · KERYDIN · Kerendia · NUZYRA · OLUMIANT · OPZELURA · Otezla · PICATO · REMICADE · SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT · SKYRIZI · SOOLANTRA · STELARA · Skyrizi · TAGRISSO · TALTZ · TREMFYA · Tremfya · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in Wayne?
Compare opticians in the Wayne area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
649
Per 100K population
120.0
County median income
$123,041
Nearest hospital
PAOLI HOSPITAL
4.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Damiano is a mixed practice specialist, with above-average Medicare volume (top 27% in PA), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Damiano experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Damiano performed 347 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Damiano receive payments from pharmaceutical companies?
Yes. Dr. Damiano received a total of $1,921 from 26 companies across 63 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Damiano's costs compare to other opticians in Wayne?
Dr. Damiano's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Damiano) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →